Sign in
Taking people in United StatesNo phase

Bone marrow cell injection compared with steroid injection for knee osteoarthritis

Compares bone marrow concentrate injections with corticosteroid injections in adults with knee osteoarthritis.

Key facts

Who runs it
Rush University Medical Center
Where
Chicago, United StatesSee the site
Trial code
Registry title
Bone Marrow Aspirate Concentrate (BMAC) vs Corticosteroid Injection
Status
Recruiting
People taking part
100 people, planned
Started
19 Jul 2022
Expected to end
31 Mar 2028
Type of study
Interventional, 3 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Autologous bone marrow aspirate concentrate (BMAC)
  • Corticosteroid injections
  • Crossover Autologous bone marrow aspirate concentrate (BMAC)
Record updated
24 August 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with long-standing knee pain from osteoarthritis (wear-and-tear arthritis of the knee). It compares injections of their own concentrated bone marrow with corticosteroid injections.

Age
18 to 70 years
Sex
All sexes
Disease stage
Primary knee osteoarthritis, KL grade 2-3 (mild to moderate joint damage on X-ray). The 7-day average pain score must be at least 4 on the VAS scale.
Earlier treatment
Pain must remain despite usual treatments for at least 6 weeks. These include activity changes, weight loss, physical therapy, pain medicines, nonsteroidal anti-inflammatory drugs or injections. People who had an injection into the affected knee in the last three months cannot join.

Main reasons for not taking part

  • Body-wide diseases such as diabetes, cancer or infections
  • Arthritis caused by a past injury (post-traumatic arthritis)
  • An injection into the affected knee joint in the last three months

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • Patients between the ages of 18-70
  • Long standing knee pain from osteoarthritis (KL grade 2-3) despite conventional treatments such as activity modification, weight loss, physical therapy, analgesics, nonsteroidal anti-inflammatory drugs, or injection therapy for at least 6 weeks
  • 7-day average pain score of at least 4 on VAS scale

Who cannot take part

  • Systemic diseases (Diabetes, malignancies, infections, etc.)
  • Post-traumatic arthritis
  • Patient had intra-articular injection on affected knee in last three months

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 70 years old?

Where in United States

  • Rush University Medical CenterChicago, United StatesContact: Carla M Edwards, PhDTaking people

About the trial

What the trial wants to find out

Prospective single-masked (study participant will be masked), randomized controlled trial to examine the influence of BMAC on patient-reported outcomes (PROs) in patients with primary knee osteoarthritis.

The 3 groups in the trial

  • Autologous (from subject to self) bone marrow aspirate concentrate (BMAC) injectionsTreatment being tested

    Autologous bone marrow aspirate concentrate (BMAC) will be removed from the subject knee body with a needle, processed and concentrated by an FDA-approved centrifuge (separator) system. The concentrated cells will be injected into the subject knee. "Autologous" means that the subject is receiving back their own cells that were collected.

    Treatment: Autologous bone marrow aspirate concentrate (BMAC)

  • Corticosteroid injectionExisting treatment, for comparison

    Corticosteroid injection group (ARM 2) will receive a sham incision.

    Treatment: Corticosteroid injections

  • Crossover GroupOther group

    Any patient in the corticosteroid injection group that shows no improvement in pain after 24 weeks (12 month follow-up if crossover), per physician discretion, will be allowed crossover to the BMAC injection group (ARM 3).

    Treatment: Crossover Autologous bone marrow aspirate concentrate (BMAC)

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Bone Marrow Aspirate Concentrate vs Corticosteroid Injection for Symptomatic Osteoarthritis (OA) of the Knee: A Randomized Controlled Trial
Plain-language title
Bone marrow cell injection compared with steroid injection for knee osteoarthritisGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Fit questions
Built from NCT05985785, who can take part
Record updated
24 August 2026